Patents by Inventor Martin Patrick HUGHES

Martin Patrick HUGHES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for the treatment of fungal infections
    Patent number: 11819533
    Abstract: The disclosure features non-irritating pharmaceutical compositions containing CD101 in pharmaceutical acceptable salt (e.g., CD101 acetate) or neutral form. The pharmaceutical compositions can be intravenously administered to a subject to treat fungal infections (e.g., candidiasis) in the subject.
    Type: Grant
    Filed: December 1, 2021
    Date of Patent: November 21, 2023
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Kenneth Bartizal, Paul Daruwala, David Hughes, Martin Patrick Hughes, Navdeep B. Malkar, Balasingam Radhakrishnan, Anuradha Vaidya
  • SYNTHESIS OF ECHINOCANDIN ANTIFUNGAL AGENT
    Publication number: 20230365629
    Abstract: The present invention relates to echinocandin cyclopeptides and to methods for preparing echinocandin cyclopeptides.
    Type: Application
    Filed: December 8, 2022
    Publication date: November 16, 2023
    Inventors: David HUGHES, Martin Patrick HUGHES, Balasingam RADHAKRISHNAN, Robert Michael HUGHES, Yannick BORGUET, Steven MCINTYRE
  • Synthesis of echinocandin antifungal agent
    Patent number: 11524980
    Abstract: The present invention relates to echinocandin cyclopeptides and to methods for preparing echinocandin cyclopeptides.
    Type: Grant
    Filed: June 14, 2019
    Date of Patent: December 13, 2022
    Assignee: Cidara Therapeutics, Inc.
    Inventors: David Hughes, Martin Patrick Hughes, Robert Michael Hughes, Balasingam Radhakrishnan, Yannick Borguet, Steven McIntyre
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS
    Publication number: 20220323539
    Abstract: The disclosure features non-irritating pharmaceutical compositions containing CD101 in pharmaceutical acceptable salt (e.g., CD101 acetate) or neutral form. The pharmaceutical compositions can be intravenously administered to a subject to treat fungal infections (e.g., candidiasis) in the subject.
    Type: Application
    Filed: December 1, 2021
    Publication date: October 13, 2022
    Inventors: Kenneth BARTIZAL, Paul DARUWALA, David HUGHES, Martin Patrick HUGHES, Navdeep B. MALKAR, Balasingam RADHAKRISHNAN, Anuradha VAIDYA
  • Compositions and methods for the treatment of fungal infections
    Patent number: 11197909
    Abstract: The disclosure features non-irritating pharmaceutical compositions containing CD101 in pharmaceutical acceptable salt (e.g., CD101 acetate) or neutral form. The pharmaceutical compositions can be intravenously administered to a subject to treat fungal infections (e.g., candidiasis) in the subject.
    Type: Grant
    Filed: July 11, 2018
    Date of Patent: December 14, 2021
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Kenneth Bartizal, Paul Daruwala, David Hughes, Martin Patrick Hughes, Navdeep B. Malkar, Balasingam Radhakrishnan, Anuradha Vaidya
  • POLYMORPH OF ECHINOCANDIN ANTIFUNGAL AGENT
    Publication number: 20210355165
    Abstract: The present invention relates to crystalline polymorphs of an echinocandin antifungal agent and novel methods for their preparation.
    Type: Application
    Filed: October 25, 2019
    Publication date: November 18, 2021
    Inventors: Martin Patrick HUGHES, Robert Michael HUGHES, Yannick BORGUET, Cen CHEN, Jianwei SHEN, Alan THOMPSON, Tracy WALKER, Yanfeng ZHANG
  • SYNTHESIS OF ECHINOCANDIN ANTIFUNGAL AGENT
    Publication number: 20210179667
    Abstract: The present invention relates to echinocandin cyclopeptides and to methods for preparing echinocandin cyclopeptides.
    Type: Application
    Filed: June 14, 2019
    Publication date: June 17, 2021
    Inventors: David HUGHES, Martin Patrick HUGHES, Robert Michael HUGHES, Balasingam RADHAKRISHNAN, Yannick BORGUET, Steven MCINTYRE
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS
    Publication number: 20200268833
    Abstract: The disclosure features non-irritating pharmaceutical compositions containing CD101 in pharmaceutical acceptable salt (e.g., CD101 acetate) or neutral form. The pharmaceutical compositions can be intravenously administered to a subject to treat fungal infections (e.g., candidiasis) in the subject.
    Type: Application
    Filed: July 11, 2018
    Publication date: August 27, 2020
    Inventors: Kenneth BARTIZAL, Paul DARUWALA, David HUGHES, Martin Patrick HUGHES, Navdeep B. MALKAR, Balasingam RADHAKRISHNAN, Anuradha VAIDYA